David McKenney - Concepedia

Author

David McKenney

Novartis (United States)

Also Known As

D McKenney, D S McKenney, D. McKenney, David McKenney, David Mckenney, McKenney, David

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Novartis (Switzerland)University of Manchester Novartis (China)Novartis Institutes for BioMedical Research

About

David McKenney is an author at Novartis (United States) specializing in microbiology, medicine, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	545
2	Health Sciences	6	6	296
3	Biochemistry	4	4	74
4	Natural Sciences	3	3	61
5	Engineering	1	1	17

David McKenney

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Broadly Protective Vaccine for <i>Staphylococcus aureus</i> Based on an in Vivo-Expressed Antigen David McKenney, Kimberly Pouliot, Ying Wang, Science	1999	368
The <i>ica</i> Locus of <i>Staphylococcus epidermidis</i> Encodes Production of the Capsular Polysaccharide/Adhesin David McKenney, Johannes Hübner, E Müller, Infection and Immunity	1998	325
Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication David McKenney, Kate Elizabeth Brown, David Allison Journal of Bacteriology Medical MicrobiologyPathogenic MicrobiologyAntimicrobial SusceptibilityPseudomonas Aeruginosa ExoproductsMedicine	1995	145
Discovery of LFF571: An Investigational Agent for <i>Clostridium difficile</i> Infection Matthew J. LaMarche, Jennifer A. Leeds, Adam Amaral, Journal of Medicinal Chemistry Bioorganic ChemistryBacteriophageInvestigational AgentBacterial PathogensPharmaceutical Chemistry	2012	116
Efficacy of LFF571 in a Hamster Model of Clostridium difficile Infection Anna Trzasko, Jennifer A. Leeds, Jens Præstgaard, Antimicrobial Agents and Chemotherapy Hamster ModelLff571 TreatmentCox RegressionAntimicrobial ChemotherapyClostridium Difficile Infection	2012	62
Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228 Folkert Reck, Alun Bermingham, Johanne Blais, Bioorganic & Medicinal Chemistry Letters Antimicrobial Drug DiscoveryAntimicrobial SusceptibilityHealth SciencesAntibioticsAntimicrobial Resistance Gene	2018	58
Localization, cloning, and expression of genetic determinants for bacteriophage resistance (Hsp) from the conjugative plasmid pTR2030 Colin Hill, Dennis Romero, David McKenney, Applied and Environmental Microbiology Hsp ExpressionMedicinePhage BiologyBacteriologyBacteriophage Resistance Mechanism	1989	46
Design, Synthesis, and Properties of a Potent Inhibitor of<i>Pseudomonas aeruginosa</i>Deacetylase LpxC Grazia Piizzi, David T. Parker, Yunshan Peng, Journal of Medicinal Chemistry	2017	45
MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis Paul Casaz, Lynne Garrity-Ryan, David McKenney, Microbiology	2006	40
Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria Colin K. Skepper, Duncan Armstrong, Carl J. Balibar, Journal of Medicinal Chemistry	2020	36

Page 1